Nathaniel Calloway

Insider Reports History

Entity
Individual
Location
C/O Anebulo Pharmaceuticals, Inc., 1415 Ranch Road 620 South, Suite 201, Lakeway, TX
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for Nathaniel Calloway
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathaniel Calloway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIFECORE BIOMEDICAL, INC. \DE\ Director Common Stock 58.1K $605K $10.42 Jul 8, 2024 Direct
LIFECORE BIOMEDICAL, INC. \DE\ Director Restricted Stock Unit 0 $0 $7.00 Feb 1, 2024 Direct
Anebulo Pharmaceuticals, Inc. Director Stock Option (right to buy) 1.66K Jun 13, 2024 Direct

Insider Reports Filed by Nathaniel Calloway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jul 8, 2024 1 $0 4 Jul 10, 2024 Director
ANEB Anebulo Pharmaceuticals, Inc. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Feb 1, 2024 2 $0 4 Feb 2, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2024 2 $0 4 Jan 10, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2023 0 $0 3 Jan 11, 2023 Director
ANEB Anebulo Pharmaceuticals, Inc. Nov 1, 2022 1 $0 4 Nov 2, 2022 Director
ANEB Anebulo Pharmaceuticals, Inc. Oct 28, 2022 0 $0 3 Nov 2, 2022 Director